Total Payments
$1,057
2024 Payments
$316.29
Companies
11
Transactions
34
Medicare Patients
1,166
Medicare Billing
$108,138
Payment Breakdown by Category
Food & Beverage$1,038 (98.1%)
Education$19.62 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,038 | 33 | 98.1% |
| Education | $19.62 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $390.02 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $172.01 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.42 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $80.89 | 4 | $0 (2023) |
| Novo Nordisk Inc | $77.90 | 4 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $65.22 | 3 | $0 (2024) |
| PFIZER INC. | $53.34 | 3 | $0 (2024) |
| Amgen Inc. | $45.15 | 2 | $0 (2024) |
| Dexcom, Inc. | $32.24 | 1 | $0 (2024) |
| Exact Sciences Corporation | $24.90 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $316.29 | 14 | AstraZeneca Pharmaceuticals LP ($113.14) |
| 2023 | $353.46 | 11 | Bayer Healthcare Pharmaceuticals Inc. ($172.01) |
| 2022 | $237.72 | 7 | AstraZeneca Pharmaceuticals LP ($146.80) |
| 2021 | $130.08 | 1 | AstraZeneca Pharmaceuticals LP ($130.08) |
| 2019 | $19.72 | 1 | PFIZER INC. ($19.72) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: DERMATOLOGY | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Endocrinology | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Dynasplint Systems Inc. | Dynasplint (Device) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: DME | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardiology | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Obesity | ||||||
| 02/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: DIABETES | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $137.40 | General |
| Category: Cardio-renal | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: DIABETES | ||||||
| 09/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiology | ||||||
| 08/25/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.23 | General |
| 08/02/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Obesity | ||||||
| 07/12/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: DIABETES | ||||||
| 06/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardio-renal | ||||||
| 05/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 03/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.12 | General |
| 02/18/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 21 | 35 | $6,439 | $3,243 |
| 2021 | 11 | 534 | 988 | $144,371 | $56,824 |
| 2020 | 13 | 611 | 1,166 | $134,963 | $48,071 |
Total Patients
1,166
Total Services
2,189
Medicare Billing
$108,138
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 35 | $6,439 | $3,243 | 50.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 168 | 358 | $88,784 | $30,728 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $15,162 | $8,384 | 55.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 85 | $14,450 | $5,544 | 38.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $7,840 | $3,711 | 47.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 66 | 193 | $10,036 | $3,421 | 34.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 26 | 26 | $1,872 | $1,528 | 81.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $2,013 | $1,385 | 68.8% |
| 85610 | Blood test, clotting time | Office | 2021 | 58 | 179 | $1,432 | $736.95 | 51.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 14 | $1,442 | $615.20 | 42.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $780.00 | $463.19 | 59.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 16 | 16 | $560.00 | $307.09 | 54.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 139 | 308 | $74,844 | $22,393 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 36 | 36 | $9,144 | $4,617 | 50.5% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 72 | 241 | $11,809 | $4,545 | 38.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 85 | $14,025 | $4,434 | 31.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 46 | 46 | $4,186 | $2,781 | 66.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 14 | 14 | $5,236 | $2,625 | 50.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 26 | 30 | $3,040 | $1,649 | 54.2% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $2,379 | $1,535 | 64.5% |
| 85610 | Blood test, clotting time | Office | 2020 | 79 | 256 | $2,048 | $1,095 | 53.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 54 | 54 | $1,296 | $1,002 | 77.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 28 | 49 | $4,851 | $551.78 | 11.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 15 | $1,485 | $490.32 | 33.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 19 | 19 | $620.00 | $352.29 | 56.8% |
About Dr. Dang Do, MD
Dr. Dang Do, MD is a Family Medicine healthcare provider based in Covington, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891953766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dang Do, MD has received a total of $1,057 in payments from pharmaceutical and medical device companies, with $316.29 received in 2024. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,038).
As a Medicare-enrolled provider, Do has provided services to 1,166 Medicare beneficiaries, totaling 2,189 services with total Medicare billing of $108,138. Data is available for 3 years (2020–2022), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Adolescent Medicine, General Practice
- Location Covington, WA
- Active Since 05/28/2008
- Last Updated 03/23/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1891953766
Products in Payments
- FARXIGA (Drug) $311.59
- Kerendia (Drug) $172.01
- JARDIANCE (Drug) $98.42
- BREZTRI (Drug) $78.43
- ZORYVE (Drug) $65.22
- Wegovy (Drug) $57.67
- Repatha (Biological) $45.15
- PAXLOVID (Drug) $33.62
- Dexcom G6 Transmitter (Medical Supply) $32.24
- Cologuard Collection Kit (Device) $24.90
- COLOGUARD (Device) $19.72
- Dynasplint (Device) $17.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Covington
Dr. Brian Galofaro, M.d, M.D
Family Medicine — Payments: $12,214
Family Medicine $12,214
Dr. Christina Mckinley, M.d, M.D
Family Medicine — Payments: $6,873
Family Medicine $6,873
Dr. Brittany Hattier, D.o, D.O
Family Medicine — Payments: $5,956
Family Medicine $5,956
Spencer Pinion, Md, MD
Family Medicine — Payments: $5,056
Family Medicine $5,056
Oliver Benes, M.d, M.D
Family Medicine — Payments: $4,052
Family Medicine $4,052
Dr. Donna Groover, M.d, M.D
Family Medicine — Payments: $3,291
Family Medicine $3,291